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UNIT A7.6Imaging of the Paranasal Sinuses
While the preferred initial imaging modality of sinonasal disease has traditionally been
computed tomography (CT), magnetic resonance imaging (MRI) has demonstrated
several unique benefits for examination of the sinonasal cavities. Specifically, MRI, in
most instances, can better distinguish between soft tissues when compared with CT. The
distinction of soft tissues becomes most clinically relevant when evaluating for possible
sinonasal tumors and when inspecting for extension of tumor or inflammation into the
orbit or intracranial spaces. It is in these areas that MRI has found its major application
in sinus imaging. This unit presents MRI techniques for imaging the sinuses with (see
Basic Protocol 2) and without (see Basic Protocol 1) contrast enhancement. The parame-
ters given here are derived from experience at 1.5 T and may need to be slightly altered
depending on the field strength and the equipment manufacturer.
BASIC
PROTOCOL 1
IMAGING OF THE PARANASAL SINUSES BY MRI WITHOUT CONTRAST
ENHANCEMENT
Magnetic resonance imaging scans can be performed at a range of field strengths.
Generally, the high signal-to-noise ratio obtained at high-field strengths allows one to
scan either faster or with higher resolution when compared with lower field strengths.
The sequences described within this unit are based on the authors’ experience with a
Siemens 1.5 T Symphony scanner, but are expected to be equally applicable to machines
from other manufacturers.
Scanning a patient or volunteer is a team effort between technologists, nurses, and
physicians. In most cases, the technologist assumes the lead role in acquiring the
appropriate images.
The following set of sequences comprises the preferred method of imaging the sinuses.
The usual sequences employed include transverse T1-weighted spin echo and fat-saturated
T2-weighted fast or turbo spin-echo (FSE) images without contrast agent administration.
Unenhanced MRI may be sufficient for diagnosis in uncomplicated inflammatory disease
if there is no suspicion that the sinonasal pathology has violated the skull base. However,
contrast enhancement is frequently necessary to assess whether a tumor or more extensive
sinonasal inflammation has violated the skull base. In cases of suspected skull-base
invasion, contrast-enhanced imaging (see Basic Protocol 2) is helpful due to its ability to
better define the intracranial margins of a lesion or to detect perineural spread of a tumor.
If a contrast agent is not used, coronal T1-weighted spin echo and T2-weighted fast
spin-echo scans should also be obtained. The duration for the imaging process including
all preparations will be ∼35 min if no contrast agent is administered. All of these sequences
are non-breathholding.
Table A7.6.1 lists the hardware necessary to perform the examination along with the
appropriate parameters. The available gradient strength will depend on the scanner, and
the echo times given below may have to be varied accordingly.
NOTE: Be sure that technologists and nurses have immediate access to any emergency
equipment that may be relevant to a given study, or that may be needed for a particular
patient, such as crash carts or oxygen.
Set up patient and equipment
1. Interview the patient to ensure that he or she has no contraindications such as cardiac
pacemakers or other implants containing ferromagnetic materials. Also, be sure to
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find out if the patient has any health conditions that may require the presence of the
special emergency equipment during the scanning procedure or any other necessary
precautions.
Generally, standard screening forms (APPENDIX 1) are used for all patients scanned in a
magnetic resonance system.
The presence of any ferromagnetic metals may be a health hazard to the patient when he
or she is inside the magnet, and will also affect the imaging. If in doubt as to the exact
composition of the items, it is best to exclude patients with any metal implants; see Shellock
and Crues (1998), Shellock and Kanal (1998a,b), Shellock and Shellock (1998a,b) and
Shellock (2001) for a discussion of what implants may be scanned safely using magnetic
resonance.
Patients may be accompanied into the magnet room by a friend or family member who can
sit in the room during the scan and comfort the patient as needed. This companion must
be screened as well to ensure the absence of loose metal objects on the body or clothing.
2. If the procedure is a research protocol, have the patient sign any necessary consent
forms.
3. Have the patient remove all jewelry and change into a gown to eliminate any metal
that may be found in clothing.
4. Have the patient wash off any mascara or other make up to avoid local tissue heating
and image artifacts.
5. Inform the patient about what will occur during the procedure, what he or she will
experience while in the magnet, as well as how to behave. Issues to discuss include
the following:
a. If earplugs or headphones are used to protect the ears from loud sounds produced
by the gradients, the patient will be asked to wear these, but will be able to
communicate with you at any time during the imaging.
b. The patient will be given a safety squeeze bulb or similar equipment to request
assistance at any time (demonstrate how this works).
c. For good results, the patient should not talk, and should avoid or minimize
swallowing or other movements during each scan—i.e., as long as the banging
sounds continue. Between scans, talking and swallowing are allowed in most
cases, but should be avoided when comparative positional studies are being
performed; the patient will be informed when this is the case.
d. Nevertheless, the patient may call out at any time that he or she feels it necessary.
Table A7.6.1 Equipment Parameters
Coil type Circularly polarized head coil (or
phased-array neck coil, if available)
Gradient coil strength 30 mT/m (or whatever the system permits)
Cardiac gating No
Peripheral gating For safety only
Respiratory gating No
Respirator If required by patient
Oxygen If required by patient
Motion cushions Useful
Contrast agent Used in Basic Protocol 2
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6. Have the patient lie down on the table. Either before or right after the patient lies
down, set up any triggering devices or other monitoring equipment that is to be used.
7. Center the patient in a head coil at the region where the key information is desired.
Make sure that the head is constrained to prevent motion.
Generally, the patient’s head is fixed so that the head is horizontal (not tilted) along the
axis of the MRI table. A dedicated head coil is employed.
8. If needed, a pillow may be placed under the knees to make the patient more
comfortable.
9. Use the centering light centered on the nasion of the patient and put him or her into
the center of the magnet.
Once this step has been performed, so long as the patient does not move on the table, the
table itself can be moved and then replaced in the same position as before without
jeopardizing the positioning of one scan relative to another.
10. If the patient is unable to hold still, provide an appropriate sedative.
Sequence 1: The pilot scan
11. To validate the patient’s position, run a scout scan to ensure correct localization of
subsequent data set acquisitions using the imaging parameters given in Table A7.6.2.
This sequence usually consists of the three orthogonal planes to allow localization. The
images are also often used later to set up total coverage for the volume of interest.
Sequence 2: Transverse T2-weighted, fat-saturated turbo spin echo (TSE)
12. Display all the coronal, sagittal, and transverse scout images in split window mode
on the scan monitor.
13. Change the imaging parameters to those listed in Table A7.6.3.
Table A7.6.2 Primary Clinical Imaging Parameters for Sequence 1 (Pilot Scan)
Patient position Supine
Scan type Gradient echo
Imaging plane (orientation) Transverse, coronal, and sagittal
Central slice or volume center Laser light centered on nasion
Echo time (TE) ≤5 msec
Repeat time (TR) ≤20 msec
Flip angle (FA) 40°
Fields of view (FOVx, FOVy) 280 mm, 280 mm
Resolution (∆x, ∆y) 2.19 mm, 2.19 mm
Number of data points collected (Nx, Ny) 128,128
Slice thickness (∆z) 10 mm
Number of slices 1 per orientation
Slice gap Not applicable
Number of acquisitions (Nacq) 1
Swap read and phase encoding No
Read direction Anterior–posterior for the transverse
images; Left–right for the coronal
image; and cranial–caudal for the
sagittal image
Scan time 9 sec
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14. Position the slices from the scout images to cover the whole sinonasal region, from
the tip of the nose to the posterior part of the sphenoid sinus in the transverse plane,
from the superior margin of the frontal sinus to the palate in the sagittal plane, and
covering both lateral margins of the maxillary sinuses. Run sequence 2 according to
Table A7.6.3.
An example is shown in Fig. A7.6.1.
Sequence 3: Transverse T1-weighted spin echo (SE)
15. Copy the imaging parameters such as number of slices, field of view, thickness of
slices, and center of slices from the performed transverse T2-weighted fat-saturated
sequence (sequence 2) and change the imaging parameters to those listed in Table
A7.6.4. Run sequence 3 according to Table A7.6.4.
An example is shown in Fig. A7.6.2.
Sequence 4: Coronal T1-weighted spin echo
16. Display the transverse images (use images from sequence 2 or 3) on the scan monitor.
17. Change the imaging parameters to those listed in Table A7.6.5. Position slices to
center of the T1- or T2-weighted spin echo image ensuring that the sinuses are fully
covered. Run sequence 4 according to Table A7.6.5.
An example is shown in Fig. A7.6.3.
Sequence 5: Coronal T2-weighted, fat-saturated turbo spin echo
18. Copy the imaging parameters such as number of slices, field of view, thickness of
slices and center of slices from the performed coronal T1-weighted sequence (se-
quence 4) and change the imaging parameters to those listed in Table A7.6.6. Run
sequence 5 according to Table A7.6.6.
Table A7.6.3 Primary Clinical Imaging Parameters for Sequence 2 (T2-Weighted
Transverse Fat-Saturated TSE)
Patient position Supine
Scan type Turbo spin echo
Imaging plane (orientation) Transverse
Central slice or volume center Centered on nasion
Echo time (TE) 62 msec
Echo train length (ETL) 7
Repeat time (TR) 4000 msec
Flip angle (FA) 150°a
Fields of view (FOVx, FOVy) 180 mm, 180 mm
Resolution (∆x, ∆y) 0.70 mm, 0.70 mm
Number of data points collected (Nx, Ny) 256, 256
Slice thickness (∆z) 4 mm
Number of slices 25
Number of slabs 1
Slice gap 0.8 mm
Number of acquisitions (Nacq) 2
Swap read and phase encoding No
Read direction Right–left
Fat suppression Yes
Scan time 302 sec
aThe system displays the flip angle of the refocusing pulse. The flip angle of the first pulse of this sequence
is 90°.
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Figure A7.6.1 This T2-weighted TSE image shows an opacification (arrow) of the right maxillary
sinus.
Table A7.6.4 Primary Clinical Imaging Parameters for Sequence 3 (Transverse
T1-Weighted Spin Echo)
Patient position Supine
Scan type Spin echo
Imaging plane (orientation) Transverse
Central slice or volume center Centered on nasion
Echo time (TE) 10 msec
Repeat time (TR) 532 msec
Flip angle (FA) 90°
Fields of view (FOVx, FOVy) 180 mm, 180 mm
Resolution (∆x, ∆y) 0.70 mm, 0.70 mm
Number of data points collected (Nx, Ny) 256, 256a
Slice thickness (∆z) 4 mm
Number of slices 25
Number of slabs 1
Slice gap 0.8 mm
Number of acquisitions (Nacq) 2
Swap read and phase encoding No
Read direction Right–left
Scan time 242 sec
aThe true number of collected phase encoding lines is 224, a reduction due to a partial Fourier factor
of 7/8.
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Figure A7.6.2 This T1-weighted SE image shows the maxillary sinus of an 8-month-old male.
Table A7.6.5 Primary Clinical Imaging Parameters for Sequence 4 (Coronal
T1-Weighted Spin Echo)
Patient position Supine
Scan type Spin echo
Imaging plane (orientation) Coronal
Central slice or volume center Centered on nasion
Echo time (TE) 10 msec
Repeat time (TR) 532 msec
Flip angle (FA) 90°
Fields of view (FOVx, FOVy) 180 mm, 180 mm
Resolution (∆x, ∆y) 0.70 mm, 0.70 mm
Number of data points collected (Nx, Ny) 256, 256a
Slice thickness (∆z) 4 mm
Number of slices 19
Number of slabs 1
Slice gap 0.8 mm
Number of acquisitions (Nacq) 2
Swap read and phase encoding No
Read direction Right–left
Scan time 242 sec
aThe true number of collected phase encoding lines is 224, a reduction due to a partial Fourier factor
of 7/8.
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Figure A7.6.3 This T1-weighted SE image shows a small retention cyst or polyp (arrow) within
the left maxillary sinus.
Table A7.6.6 Primary Clinical Imaging Parameters for Sequence 5 (Coronal
T2-Weighted Fat-Saturated TSE)
Patient position Supine
Scan type Turbo spin echo
Imaging plane (orientation) Coronal
Central slice or volume center Centered on nasion
Echo time (TE) 62 msec
Echo train length (ETL) 7
Repeat time (TR) 4000 msec
Flip angle (FA) 150°a
Fields of view (FOVx, FOVy) 180 mm, 180 mm
Resolution (∆x, ∆y) 0.70 mm, 0.70 mm
Number of data points collected (Nx, Ny) 256, 256
Slice thickness (∆z) 4 mm
Number of slices 19
Number of slabs 1
Slice gap 0.8 mm
Number of acquisitions (Nacq) 2
Swap read and phase encoding No
Read direction Right–left
Fat suppression Yes
Scan time 302 sec
aThe system displays the flip angle of the refocusing pulse. The flip angle of the first pulse of this sequence
is 90°.
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BASIC
PROTOCOL 2
IMAGING OF THE PARANASAL SINUSES BY MRI WITH CONTRAST
ENHANCEMENT
In cases of suspected skull base, intracranial, intraorbital, or perineural extension of
sinonasal pathology, the administration of a contrast agent is advised. In addition, some
have suggested a role for post-contrast images if a solid mass cannot be distinguished
from a cystic lesion on the non-contrast-enhanced examination, as characteristic enhance-
ment of a cyst wall can often be appreciated. If a contrast agent is employed, transverse
and coronal T1-weighted, fat-suppressed, contrast-enhanced sequences should be ob-
tained. If a contrast agent is administered, the duration of the imaging process including
all preparations will be ∼50 min. All these sequences are non-breathholding.
Materials
Normal saline (0.9% NaCl), sterile
Gadolinium-based MR contrast agent (e.g., Magnevist, Omniscan, or Prohance)
1. Perform Basic Protocol 1, steps 1 to 6.
2. Establish an intravenous line from which the contrast agent can be injected, and attach
this line securely to the patient so that movement into or out of the magnet will not
pull at the patient’s arm.
It is preferable to insert the line prior to imaging and to leave the patient in the magnet, so
that there is no intervening motion between the scans run before contrast agent injection
and those run after injection.
3. Perform Basic Protocol 1, steps 7 to 10.
4. Perform Basic Protocol 1, sequences 1, 2, and 3.
5. Administer the contrast agent. A dose of 0.2 mmol/kg gadolinium is usually given at
a rate of 1 ml/sec.
Table A7.6.7 Primary Clinical Imaging Parameters for Sequence 6 (Transverse
T1-Weighted Fat-Saturated Spin Echo)
Patient position Supine
Scan type Spin echo
Imaging plane (orientation) Transverse
Central slice or volume center Centered on nasion
Echo time (TE) 10 msec
Repeat time (TR) 500 msec
Flip angle (FA) 90°
Fields of view (FOVx, FOVy) 180 mm, 180 mm
Resolution (∆x, ∆y) 0.70 mm, 0.70 mm
Number of data points collected (Nx, Ny) 256, 256a
Slice thickness (∆z) 4 mm
Number of slices 25 (total)
Number of slabs 2
Slice gap 0.8 mm
Number of excitations (NEX) 2b
Number of acquisitions (Nacq) 2
Swap read and phase encoding No
Read direction Right–left
Fat suppression Yes
Scan time 390 sec
aThe true number of collected phase encoding lines is 192, a reduction due to a partial Fourier factor
of 3/4.
bThe number of cocatenation is set to be 2. This means that only half of the total slices will be excited
during a given repeat time.
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Figure A7.6.4 This T1-weighted SE image with fat saturation shows contrast enhancement of the
mucous membranes (arrow) of the opacified right maxillary sinus.
Table A7.6.8 Primary Clinical Imaging Parameters for Sequence 7 (Coronal
T1-Weighted Fat-Saturated Spin Echo)
Patient position Supine
Scan type Spin echo
Imaging plane (orientation) Coronal
Central slice or volume center Centered on nasion
Echo time (TE) 10 msec
Repeat time (TR) 723 msec
Flip angle (FA) 90°
Fields of view (FOVx, FOVy) 180 mm, 180 mm
Resolution (∆x, ∆y) 0.70 mm, 0.70 mm
Number of data points collected (Nx, Ny) 256, 256a
Slice thickness (∆z) 4 mm
Number of slices 19
Number of slabs 1
Slice gap 0.8 mm
Number of acquisitions (Nacq) 2
Swap read and phase encoding No
Read direction Right–left
Fat suppression Yes
Scan time 281 sec
aThe true number of collected phase encoding lines is 192, a reduction due to a partial Fourier factor
of 3/4.
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6. Perform the following sequences 3 min post-injection.
Sequence 6: Transverse T1-weighted, fat-saturated spin echo
7. Copy the imaging parameters such as number of slices, field of view, thickness of
slices, and center of slices from the performed transverse T1-weighted sequence
(sequence 3) and change the imaging parameters to those listed in Table A7.6.7. Run
sequence 6 according to Table A7.6.7.
An example is shown in Figure A7.6.4.
Sequence 7: Coronal T1-weighted, fat-saturated spin echo
8. Copy the imaging parameters such as number of slices, field of view, thickness of
slices, and center of slices from the performed coronal T1-weighted sequence (se-
quence 4) and change the imaging parameters to those listed in Table A7.6.8. Run
sequence 7 according to Table A7.6.8.
An example is shown in Fig. A7.6.5.
COMMENTARY
Background Information
The examination of the anatomy and pathol-
ogy of paranasal sinuses, as seen by MRI as
well as CT, shows a wide variety of findings in
a range of 15% to 40% of all adults that undergo
imaging (Conner et al., 1989). Some of the
findings can be correlated to acute upper respi-
ratory infection and allergic episodes with a
typical seasonal pattern (Moore et al., 1986).
But most of the abnormalities in the paranasal
sinuses were unrelated to the patients’ present-
ing problems (Moser et al., 1991) and are,
therefore, often reported as incidental findings
on scans performed for indications other than
the evaluation of a paranasal sinus pathology.
Thus, many people with inflammatory changes
in their sinuses demonstrated on MRI do not
have symptoms classically attributed to sinusi-
tis (Cooke and Hadley, 1991).
The most common inflammatory abnor-
malities noted on imaging studies include
opacified sinus cavities, intrasinus air-fluid lev-
els and polyps, mucoperiosteal thickening, iso-
lated increased signal of the mucosal lining,
mucus retention cysts, and fungal concretions
(Zinreich, 1990). Abnormalities were most
commonly seen in the ethmoid sinuses fol-
lowed by the maxillary cavities, and, to a lesser
extent, in the sphenoid and frontal sinuses
(Wani et al., 2001).
Findings of high significance on paranasal
sinus studies are mastoiditis as a known cause
Figure A7.6.5 This T1-weighted SE image with fat saturation shows contrast enhancement of the
mucous membranes (arrow) of the opacified right maxillary sinus, same patient as in Figure A7.6.4.
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of lateral venous sinus thrombosis (Fink and
McAuley, 2002), and sphenoid mucoceles. Al-
though benign, sphenoid mucoceles may in-
volve the orbit and cause acute restrictive
ophthalmoplegia, proptosis, and reduced visual
acuity (Conner et al., 1989).
Malignant pathologies involving the
paranasal sinuses are rare, but nasopharyngeal
carcinoma may spread to the paranasal sinuses.
Maxillary sinus infiltration by this tumor is
most common but contrast-enhanced MRI al-
lows differentiating tumor from inflammatory
changes in all sinuses (Chong et al., 1998). MR
imaging is also indicated for the evaluation of
primary tumors of the sinuses and nasal cavity,
including squamous cell carcinoma, esthe-
sioneuroblastoma, lymphoma, and inverted
papilloma. In the presence of an aggressive
tumor, particular attention should be directed
toward dural thickening or invasion, periorbital
invasion, or perineural extension. In addition,
the pterygopalatine fossa should be examined
for evidence of posterior direct or perineural
extension in the presence of maxillary sinus or
hard palate involvement by tumor.
Magnetic resonance imaging has proven to
be a useful tool for imaging the paranasal si-
nuses and nasal cavities. Of particular interest
in this region is the ability to distinguish lesions
that are highly cellular with little free water,
demonstrating intermediate signal on T2-
weighted images, most likely representing tu-
mor, from those lesions that have significant
amounts of serous and mucinous secretions,
very high in signal on T2-weighted images, that
more likely represent an inflammatory or post-
obstructive process containing predominantly
free water (Hasso and Lambert, 1994).
Furthermore, the multiplanar capabilities of
MRI allow identifying tumor margins demon-
strating the extent of the disease and specifically
the relationship to key landmarks critical for fur-
ther surgical treatment (Weissman et al., 1990).
CT remains the examination of choice for
evaluation of the thin cortical bones of the
osteomeatal complex, and for visualization of
osteolytic regions with high sensitivity and spa-
tial resolution (Weissman et al., 1990). Another
indication for CT is for evaluation of osteomas
involving the paranasal sinuses (Beahm et al.,
1990).
Critical Parameters and
Troubleshooting
The high magnetic field strength of 1.5 T
magnets and T2-weighted spin echo techniques
reveal a remarkably intense signal from abnor-
mal tissue in the paranasal sinuses. Inflamma-
tory disease in the maxillary, sphenoid, eth-
moid, and frontal sinuses is detected and dem-
onstrated with greater clarity than any other
available technique. The additional administra-
tion of gadolinium as a contrast agent allows
detection and characterization of malignant
processes and their margins, along with detec-
tion of extension and infiltration when fat-satu-
rated T1-weighted spin echo techniques are
applied (Moore et al., 1986).
The majority of the pathological processes
can be adequately imaged by transverse T1- and
T2-weighted pulse sequences. When more tis-
sue specific information is required, additional
coronal and sagittal planes are helpful for tu-
mors that infiltrate the skull base or are sur-
rounded by air-filled sinuses (Beahm et al.,
1990).
High spatial resolution is desired so that
small areas of signal variation mostly due to
edema are not missed. It is also important to
center the slice-selecting planes in the trans-
verse, coronal, and sagittal orientation to per-
form a comparison with the opposite side in
order to identify any area of abnormality and
differentiate between pathology and anatomi-
cal variation.
Anticipated Results
A variety of findings within the paranasal
sinuses can be identified utilizing magnetic
resonance imaging and computed tomography.
The primary role of CT is in visualizing the
thin cortical bones of the osteomeatal complex
in order to precisely identify bony abnormali-
ties with high sensitivity and spatial resolution.
MRI is considered by many the imaging
modality of choice for evaluating any soft-tis-
sue lesion of the paranasal sinuses. These le-
sions may range from rather less significant
importance for the patient with no further treat-
ment such as mild sinus inflammation, polyps,
mucus retention cysts, mucoperiosteal thicken-
ing, or simple inflammatory increased signal of
the epithelial lining, to less common lesions
such as fungal concretions, sphenoid mucoce-
les, and infections such as mastoiditis, which
may result in further even life threatening com-
plications.
Although a specific diagnosis can be sug-
gested in most cases by other means of visuali-
zation, only MRI has the potential to demon-
strate the extent of the disease with high preci-
sion.
The visualization of malignancies such as
nasopharyngeal carcinoma, sinus carcinoma,
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lymphoma, esthesioneuroblastoma, or nasal
cavity tumors can be accomplished with a
maximum degree of spatial resolution by MRI
and thereby help to identify routes of tumor
spread and key surgical landmarks for further
therapy.
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